Lupin Digital Health, The American College of Cardiology collaborate to deliver in home cardiovascular care with Digital Therapeutics in India Ruchika Sharma25 July 2023 10:00 AM ISTAs part of this collaboration, Lupin Digital Health will leverage ACC's CardioSmart platform, guidelines, and workbooks to guide healthcare...
Lupin incorporates wholly owned subsidiary for neuro-rehabilitation business Ruchika Sharma23 July 2023 4:00 PM ISTMumbai: Lupin has informed in a BSE filing that the company has incorporated Lupin Atharv Ability Limited, wholly owned subsidiary, for...
Lupin arm unveils Luforbec 100/6 for adult asthma, COPD treatment in Germany Ruchika Sharma22 July 2023 2:30 PM ISTMumbai: Hormosan Pharma GmbH (Hormosan), Lupin’s wholly-owned subsidiary in Germany, announced the launch of Luforbec 100/6 (beclometasone 100 µg / ...
Lupin bags USFDA nod for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets Ruchika Sharma22 July 2023 11:41 AM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received tentative approval from the United States Food and Drug...
USFDA issues two observations for Lupin Nagpur facility Ruchika Sharma13 July 2023 1:04 PM ISTMumbai: Lupin has announced the United States Food and Drug Administration (USFDA) has concluded the inspection at the...
Lupin Pithampur Unit-2 facility gets EIR from USFDA Ruchika Sharma12 July 2023 11:15 AM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received the Establishment Inspection Report (EIR) from the United States...
Lupin Dolutegravir Tablets for Oral Suspension gets tentative USFDA nod for HIV/AIDS Ruchika Sharma4 July 2023 5:38 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin bags USFDA nod for generic equivalent of Nascobal Nasal Spray Ruchika Sharma4 July 2023 11:35 AM ISTMumbai:Global pharma major, Lupin Limited, has announced that the Company has received approval from the United States Food and Drug Administration...
Lupin gets USD 25 million from AbbVie for novel MALT1 inhibitor program to treat hematological cancers Medical Dialogues Bureau1 July 2023 3:16 PM ISTNew Delhi: Drug major Lupin on Thursday said it has received USD 25 million (around Rs 205 crore) from AbbVie Inc for meeting a key development...
Lupin receives over Rs 205 crore from AbbVie for meeting key product development milestone Ruchika Sharma30 Jun 2023 2:00 PM ISTMumbai: Global pharma major Lupin Limited has announced the achievement of a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue ...
Establish self-regulatory body to maintain pharma products quality: Dr Mansukh Mandaviya urges industry Ruchika Sharma24 Jun 2023 1:30 PM ISTMinister said that the country is marching ahead in the field of research and innovation as the government has opened its research facilities to all...
Lupin unveils Rufinamide Oral Suspension for seizure disorder in US Ruchika Sharma23 Jun 2023 2:41 PM ISTMumbai: Global pharma major Lupin Limited today announced the launch of Rufinamide Oral Suspension, 40 mg/mL to market a generic equivalent of Banzel...
